BAX Baxter International Inc.

IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces an Investigation of Baxter International Inc. and Advises Investors with Losses to Contact the Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) concerning possible violations of federal securities laws.

To get more information about this investigation, please contact Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or by email at [email protected].

The investigation concerns whether Baxter and certain of its officers and/or directors violated federal securities laws. On April 14, 2017, the Company disclosed that one of its employees received a grand jury subpoena related to a criminal investigation by the Antitrust Division of the U.S. Department of Justice into the Company’s sales practices of intravenous saline.

Lundin Law PC was founded by Brian Lundin, a securities litigator based in Los Angeles dedicated to upholding shareholders’ rights.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

EN
26/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Baxter International Inc.

Moody's Ratings affirms Baxter at Baa2; revises outlook to negative fr...

Moody's Ratings (Moody's) affirmed Baxter International Inc.'s (Baxter) ratings, including its Baa2 senior unsecured ratings and Prime-2 commercial paper rating. At the same time, we revised the outlook to negative from stable. The ratings affirmation considers Baxter's good scale and diversity as...

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Baxter International Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 17 June 2025 in which we reassessed the appropriateness of the ratings in the con...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch